These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17147833)

  • 41. Cost-Effectiveness of Dolutegravir as a First-Line Treatment Option in the HIV-1-Infected Treatment-Naive Patients in Russia.
    Tremblay G; Chounta V; Piercy J; Holbrook T; Garib SA; Bukin EK; Punekar YS
    Value Health Reg Issues; 2018 Sep; 16():74-80. PubMed ID: 30296624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system.
    Moreno S; González J; Lekander I; Martí B; Oyagüez I; Sánchez-de la Rosa R; Casado MA
    Clin Ther; 2010 Dec; 32(13):2232-45. PubMed ID: 21316539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Individualized positron emission tomography-based isotoxic accelerated radiation therapy is cost-effective compared with conventional radiation therapy: a model-based evaluation.
    Bongers ML; Coupé VM; De Ruysscher D; Oberije C; Lambin P; Uyl-de Groot CA
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):857-65. PubMed ID: 25752401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Cost-Effectiveness Analysis of Clopidogrel for Patients with Non-ST-Segment Elevation Acute Coronary Syndrome in China.
    Cui M; Tu CC; Chen EZ; Wang XL; Tan SC; Chen C
    Adv Ther; 2016 Sep; 33(9):1600-11. PubMed ID: 27397588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's disease in the UK and Germany.
    Walter E; Odin P
    J Med Econ; 2015 Feb; 18(2):155-65. PubMed ID: 25348011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan Africa.
    Barker C; Dutta A; Klein K
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21648. PubMed ID: 28770597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.
    Freedberg KA; Kumarasamy N; Losina E; Cecelia AJ; Scott CA; Divi N; Flanigan TP; Lu Z; Weinstein MC; Wang B; Ganesh AK; Bender MA; Mayer KH; Walensky RP
    AIDS; 2007 Jul; 21 Suppl 4(Suppl 4):S117-28. PubMed ID: 17620747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands.
    Hubben GA; Bos JM; Veltman-Starkenburg CA; Stegmeijer S; Finnern HW; Kappelhoff BS; Simpson KN; Tramarin A; Postma MJ
    Cost Eff Resour Alloc; 2007 Nov; 5():15. PubMed ID: 18034881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness of intensive care for hospitalized COVID-19 patients: experience from South Africa.
    Cleary SM; Wilkinson T; Tamandjou Tchuem CR; Docrat S; Solanki GC
    BMC Health Serv Res; 2021 Jan; 21(1):82. PubMed ID: 33482807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-Utility Analysis of Dolutegravir- Versus Efavirenz-Based Regimens as a First-Line Treatment in Adult HIV/AIDS Patients in Ethiopia.
    Belay YB; Ali EE; Chung KY; Gebretekle GB; Sander B
    Pharmacoecon Open; 2021 Dec; 5(4):655-664. PubMed ID: 34133017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Costs of providing HIV care and optimal allocation of HIV resources in Guyana.
    Suraratdecha C; Stuart RM; Edwards M; Moore R; Liu N; Wilson DP; Albalak R
    PLoS One; 2020; 15(10):e0238499. PubMed ID: 33119591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness analysis of the national decentralization policy of antiretroviral treatment programme in Zambia.
    Miyano S; Syakantu G; Komada K; Endo H; Sugishita T
    Cost Eff Resour Alloc; 2017; 15():4. PubMed ID: 28413361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incorporating the HIV Infant Tracking System into standard-of-care early infant diagnosis of HIV services in Kenya: a cost-effectiveness analysis of the HITSystem randomised trial.
    Finocchario-Kessler S; Goggin K; Wexler C; Maloba M; Gautney B; Khamadi S; Lwembe R; Babu S; Sweat M
    Lancet Glob Health; 2023 Aug; 11(8):e1217-e1224. PubMed ID: 37474229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of a Pharmacogenomic Test for Stratified Isoniazid Dosing in Treatment of Active Tuberculosis.
    Rens NE; Uyl-de Groot CA; Goldhaber-Fiebert JD; Croda J; Andrews JR
    Clin Infect Dis; 2020 Dec; 71(12):3136-3143. PubMed ID: 31905381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimating the cost-effectiveness of nutrition supplementation for malnourished, HIV-infected adults starting antiretroviral therapy in a resource-constrained setting.
    Koethe JR; Marseille E; Giganti MJ; Chi BH; Heimburger D; Stringer JS
    Cost Eff Resour Alloc; 2014; 12():10. PubMed ID: 24839400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Price of Prevention: Cost Effectiveness of Biomedical HIV Prevention Strategies in South Africa.
    Moodley N; Gray G; Bertram M
    Clin Res HIV AIDS; 2016; 3(1):. PubMed ID: 28824960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Costs of home-delivered antiretroviral therapy refills for persons living with HIV: evidence from a pilot randomized controlled trial in KwaZulu-Natal, South Africa.
    Tseng AS; Barnabas RV; van Heerden A; Ntinga X; Sahu M
    medRxiv; 2024 Jun; ():. PubMed ID: 38853918
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.